CLEOCIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cleocin Hydrochloride, and when can generic versions of Cleocin Hydrochloride launch?
Cleocin Hydrochloride is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in CLEOCIN HYDROCHLORIDE is clindamycin hydrochloride. There are fifty-five drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the clindamycin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cleocin Hydrochloride
A generic version of CLEOCIN HYDROCHLORIDE was approved as clindamycin hydrochloride by SUN PHARM INDS LTD on February 2nd, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLEOCIN HYDROCHLORIDE?
- What are the global sales for CLEOCIN HYDROCHLORIDE?
- What is Average Wholesale Price for CLEOCIN HYDROCHLORIDE?
Summary for CLEOCIN HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 75 |
| Clinical Trials: | 11 |
| What excipients (inactive ingredients) are in CLEOCIN HYDROCHLORIDE? | CLEOCIN HYDROCHLORIDE excipients list |
| DailyMed Link: | CLEOCIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for CLEOCIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Missouri-Columbia | Phase 4 |
| University of California, Los Angeles | Phase 4 |
| Roswell Park Cancer Institute | Phase 4 |
Pharmacology for CLEOCIN HYDROCHLORIDE
| Drug Class | Lincosamide Antibacterial |
| Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
US Patents and Regulatory Information for CLEOCIN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | CLEOCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 050162-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Pfizer | CLEOCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 050162-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Pfizer | CLEOCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 050162-003 | Apr 14, 1988 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
